Cite

HARVARD Citation

    Pal, S. et al. (2021). Cabozantinib in Combination With Atezolizumab for Advanced Renal Cell Carcinoma: Results From the COSMIC-021 Study. Journal of clinical oncology. 39 (33), pp. 3725-3736. [Online]. 
  
Back to record